CLOs on the Move

Community Action of Minneapolis

www.campls.org

 
Community Action of Minneapolis is a Minneapolis, MN-based company in the Non-profit sector.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Crohn's and Colitis Foundation of America

Crohn's and Colitis Foundation of America is a New York, NY-based company in the Non-Profit sector.

Clinton Presidential Fndtn

Clinton Presidential Fndtn is a Little Rock, AR-based company in the Retail sector.

Sun Life Family Health Center

Sun Life Family Health Center is a Casa Grande, AZ-based company in the Non-profit sector.

Museum of Science and Industry

The Museum of Science and Industry, Chicago—one of the largest science museums in the world—is home to more than 400,000 square feet of hands-on exhibits designed to spark scientific inquiry and creativity.

National Organization for Rare Disorders

The National Organization for Rare Disorders, a 501(c)(3) organization, is an independent patient advocacy organization dedicated to helping individuals with rare diseases and the organizations that serve them. NORD, along with its 280 patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient support services. NORD serves all stakeholders in the rare disease community, including patients and their families, patient organizations, researchers, medical professionals, medical students, and companies developing orphan products. NORD also works closely with many government agencies, most notably the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). All NORD programs are focused on one ultimate goal -- to improve the lives of individuals and families affected by rare diseases. NORD is the official sponsor of Rare Disease Day in the U.S., an observance day held on the last day of February each year worldwide. Its goals are to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families.